BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12033781)

  • 1. Bovine papillomavirus type 1 E6-induced sensitization to apoptosis is distinct from its transforming activity.
    Liu Z; Liu Y; Hong Y; Rapp L; Androphy EJ; Chen JJ
    Virology; 2002 Apr; 295(2):230-7. PubMed ID: 12033781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.
    Rapp L; Liu Y; Hong Y; Androphy EJ; Chen JJ
    Oncogene; 1999 Jan; 18(3):607-15. PubMed ID: 9989810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
    Chen JJ; Hong Y; Androphy EJ
    Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
    Scobie L; Jackson ME; Campo MS
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127.
    Kilk A; Rausalu K; Ustav M
    Chem Biol Interact; 2006 Feb; 159(3):205-12. PubMed ID: 16413007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X
    Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular factors are required to activate bovine papillomavirus-1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation.
    Haugen TH; Lace MJ; Ishiji T; Sameshima A; Anson JR; Turek LP
    Virology; 2009 Jun; 389(1-2):82-90. PubMed ID: 19410271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4.
    O'Brien V; Ashrafi GH; Grindlay GJ; Anderson R; Campo MS
    Virology; 1999 Mar; 255(2):385-94. PubMed ID: 10069964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and genetic definition of a bovine papillomavirus type 1 E7 protein and absence of a low-copy-number phenotype exhibited by E5, E6, or E7 viral mutants.
    Jareborg N; Alderborn A; Burnett S
    J Virol; 1992 Aug; 66(8):4957-65. PubMed ID: 1321280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb-independent induction of apoptosis by bovine papillomavirus type 1 E7 in response to tumor necrosis factor alpha.
    Liu Y; Hong Y; Androphy EJ; Chen JJ
    J Biol Chem; 2000 Oct; 275(40):30894-900. PubMed ID: 10887172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV 16 E6 blocks TNF-mediated apoptosis in mouse fibroblast LM cells.
    Duerksen-Hughes PJ; Yang J; Schwartz SB
    Virology; 1999 Nov; 264(1):55-65. PubMed ID: 10544129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
    Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
    Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.
    Tsirimonaki E; Ullah R; Marchetti B; Ashrafi GH; McGarry L; Ozanne B; Campo MS
    Virus Res; 2006 Feb; 115(2):158-68. PubMed ID: 16168512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine papillomavirus E7 oncoprotein inhibits anoikis.
    DeMasi J; Chao MC; Kumar AS; Howley PM
    J Virol; 2007 Sep; 81(17):9419-25. PubMed ID: 17596310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the human papillomavirus E6 PDZ-binding motif correlates with an enhanced morphological transformation of immortalized human keratinocytes.
    Watson RA; Thomas M; Banks L; Roberts S
    J Cell Sci; 2003 Dec; 116(Pt 24):4925-34. PubMed ID: 14625386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BPV-4 induces amplification and activation of 'silent' BPV-1 in a sub-line of C127 cells.
    Smith KT; Coggins LW; Doherty I; Pennie WD; Cairney M; Campo MS
    Oncogene; 1993 Jan; 8(1):151-6. PubMed ID: 8380914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the transforming functions of bovine papillomavirus type 4.
    Pennie WD; Grindlay GJ; Cairney M; Campo MS
    Virology; 1993 Apr; 193(2):614-20. PubMed ID: 8384749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CuZn-SOD suppresses the bovine papillomavirus-induced proliferation of fibroblasts.
    Rausalu K; Karo-Astover L; Kilk A; Ustav M
    APMIS; 2007 Dec; 115(12):1415-21. PubMed ID: 18184412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.
    DeMasi J; Huh KW; Nakatani Y; Münger K; Howley PM
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11486-91. PubMed ID: 16081543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.
    Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL
    Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.